Your Steward Learning Hub: Upholding Excellence in Everyday Practice

Welcome, Steward! 

Your “Clinical Reflections” quiz results highlight your commitment to consistent, high-quality care. The ADVENT program brings together emerging data and perspectives to support informed clinical decision-making. Explore curated resources to help translate the latest insights into practice.

What You'll Discover in Your Steward Learning Hub

Dive into curated resources that emphasize best practices and contextualize advancements based on practicality, safety, and accessibility.

Ready to push boundaries? Explore your personalized resources to reinforce and build on your practice 
 

The Weight of Breath: The Impact of Pediatric Asthma on Patients and Caregivers
Pulmonology
videoanimation

The Weight of Breath: The Impact of Pediatric Asthma on Patients and Caregivers

FeNO Is a Noninvasive Biomarker That Can Support Diagnosis and Management for Asthma Patients
Pulmonology
Infographic

FeNO Is a Noninvasive Biomarker That Can Support Diagnosis and Management for Asthma Patients

Mechanisms of Production and Clinical Impact of IgE
Pulmonology
videoanimation

Mechanisms of Production and Clinical Impact of IgE

How Type 2 Inflammation Drives Eosinophils in Asthma
Pulmonology
videoanimation

How Type 2 Inflammation Drives Eosinophils in Asthma

What Is The COPD Vicious Cycle?
Pulmonology
expert video

What Is The COPD Vicious Cycle?

Eosinophils: A Biomarker in COPD
Pulmonology
Infographic

Eosinophils: A Biomarker in COPD

ADVENT On Air | Many Faces of COPD: From Phenotypes to Endotypes
Pulmonology
Podcast

ADVENT On Air | Many Faces of COPD: From Phenotypes to Endotypes

MAT-GLB-2602169 - 1.0 - 05/2026

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2026 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-US-2305040 v4.0 – P Expiration Date: 10/16/2027

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region